Patient confidentiality is a major reason why minors do not seek out prevention, testing, and treatment services for sexually transmitted infections (STIs) and HIV.
In a research letter published in JAMA, authors assessed existing minor consent laws surrounding sexually transmitted infection (STI) and HIV services in the United States, comparing confidentiality protection measures across the 50 states and the District of Columbia.
A significant reason why some adolescents do not seek out these services is confidentiality, including concern that a parent or guardian will find out, especially if the child is on their health insurance plan.
To address this barrier and encourage STI/HIV testing, treatment, and prevention, states have enacted statutes granting minors legal capacity to consent to these services without the involvement of their parent or guardian.
“Although reviews of STI/HIV minor consent laws exist, many are dated, have unclear methodology, provide conflicting information, or lack details needed to serve adolescents, researchers, and clinicians,” the authors of the letter wrote.
In this assessment, laws were divided into consent to:
Most states defined age of minority as younger than 18, with Alabama and Nebraska defining it as younger than 19, and Mississippi and Pennsylvania defining it as younger than 21.
As of 2021, in all 51 jurisdictions across the states and the District of Columbia, minors can independently consent to STI/HIV testing and treatment.
Most states allow all minors to consent to STI (n = 43) and HIV (n = 42) testing and treatment without a minimum age. In the remaining states, minors can consent to STI/HIV testing and treatment starting between ages 12 and 14 years, depending on the state.
For prevention, minors can consent to STI prevention services in 33 states, and HIV prevention services in 35 states. Additionally, 14 states established criteria individuals must meet in order to consent independently.
The following conditions must be met to some degree for minors to be legally able to consent to care in these 14 states:
Approximately half of states have the following disclosure rules for clinicians:
Additionally, surgical or nonsurgical care must be deemed “essential to the health or life of such child in the opinion of the performing physician and a consultant physician if one is available” in some states.
“Trainings, policies, and procedures that support and routinize the application of these statutes may empower clinicians to rely on them more confidently in practice,” the authors said. “Ensuring that clinicians, researchers, and minors understand and trust these minor consent laws may expand access to STI/HIV services for youth.”
Reference
Nelson KM, Skinner A, Underhill K. Minor consent laws for sexually transmitted infection and HIV services. JAMA. 2022;328(7):674-676. doi:10.1001/jama.2022.10777
PAH Treatment Benefits Extend to Patients With Repaired Congenital Heart Disease
March 14th 2025Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ranges from 4% to 28%, according to studies from the US and Europe—and that the prevalence of these comorbid condition is on the rise.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy
March 13th 2025The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.
Read More